Author

T. Longerich

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 3 Approach:statistical model· 3 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Organism:human· 2 Organism:mouse· 2 Research Focus:cell signaling & trafficking· 1

Frequent Co-Authors

L. R. Heij· 2 shared M. Castoldi· 2 shared R. Pellegrino· 2 shared T. Luedde· 2 shared U. P. Neumann· 2 shared A. Ali· 1 shared A. Billeter· 1 shared A. J. Rose· 1 shared

Activity by Year

2023-2023 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

L. R. Heij

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

KIF23 regulation by miR-107 controls replicative tumor cell fitness in mouse and human hepatocellular carcinoma

M. Castoldi, S. Roy, C. Lohr, R. Pellegrino, M. Vucur, M. T. Singer, V. Buettner, M. A. Dille, L. R. Heij, L. Zender, U. P. Neumann, T. Longerich, C. Roderburg, T. Luedde

bioRxiv · Nov 20, 2023Cancer Biology

Beneficial effects of intermittent fasting in NASH and subsequent HCC development are executed by concerted PPAR alpha and PCK1 action in hepatocytes

S. Gallage, A. Ali, J. E. Barragan Avila, N. Seymen, P. Ramadori, V. Joerke, L. Zizmare, J. Kosla, X. Li, E. Focaccia, S. Yousuf, T. Sijmonsma, M. Rahbari, K. S. Kommoss, A. Billeter, , M. Heikenwalder

This study shows intermittent fasting prevents NASH and HCC by PPAR alpha and PCK1 working together in liver cells.

bioRxiv · Oct 23, 2023 · PreprintCancer Biology

Uncovering novel roles of miR-122 in the pathophysiology of the liver: Potential interaction with NRF1 and E2F4 signaling

M. Paluschinski, J. Schira-Heinen, R. Pellegrino, L. R. Heij, J. Bednarsch, U. P. Neumann, T. Longerich, K. Stuehler, T. Luedde, M. Castoldi

This study identifies miR-122's role in liver disease by showing its antagonistic effects on NRF1 and E2F4 and its impact on proteins linked to malignancy.

bioRxiv · Jun 30, 2023Cancer Biology